Alcon AG (Switzerland) Today

ALC Stock  CHF 60.08  0.66  1.09%   

Performance

Weakest

 
Weak
 
Strong

Odds Of Distress

Tiny

 
High
 
Low
Alcon AG is selling for under 60.08 as of the 9th of February 2026; that is 1.09 percent decrease since the beginning of the trading day. The stock's lowest day price was 59.88. Alcon AG has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 11th of November 2025 and ending today, the 9th of February 2026. Click here to learn more.
Business Domain
Health Care Equipment & Services
Category
Healthcare
Classification
Health Care
Alcon, Inc. develops and manufactures eye care products for eye care professionals and their patients. operates independently of Novartis AG as of April 9, 2019. ALCON N operates under Medical Instruments Supplies classification in Switzerland and is traded on Switzerland Exchange. The company has 491.2 M outstanding shares. More on Alcon AG

Alcon Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Alcon AG's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Alcon AG or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Business ConcentrationHealth Care Equipment & Supplies, Health Care Equipment & Services, Health Care, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors)
Alcon AG's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Alcon AG's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Debt Levels
By employing borrowed capital, Alcon AG can potentially magnify investment returns. Examining the debt-to-assets ratio offers investors perspective on Alcon AG's use of financial leverage and reveals what portion of Alcon AG's asset base relies on creditor financing.
Liquidity
Alcon AG cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. Alcon AG has accumulated 5.14 B in total debt with debt to equity ratio (D/E) of 19.5, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Alcon AG has a current ratio of 1.07, suggesting that it is in a questionable position to pay out its financial obligations in time and when they become due. Debt can assist Alcon AG until it has trouble settling it off, either with new capital or with free cash flow. So, Alcon AG's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Alcon AG sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Alcon to invest in growth at high rates of return. When we think about Alcon AG's use of debt, we should always consider it together with cash and equity.

Other Cashflows From Financing Activities

(9.66 Million)
Alcon AG (ALC) is traded on SIX Swiss Exchange in Switzerland and employs 25,000 people. Alcon AG is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 30.03 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Alcon AG's market, we take the total number of its shares issued and multiply it by Alcon AG's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Alcon AG operates under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 491.2 M outstanding shares. Alcon AG has accumulated about 721 M in cash with 2.08 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.48.
Check Alcon AG Probability Of Bankruptcy
Ownership Allocation
Alcon AG holds a total of 491.2 Million outstanding shares. Over half of Alcon AG's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Alcon AG. Please watch out for any change in the institutional holdings of Alcon AG as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Alcon Ownership Details

Alcon AG Historical Income Statement

At this time, Alcon AG's Interest Income is fairly stable compared to the past year. View More Fundamentals

Alcon Stock Against Markets

Alcon Stock Analysis Notes

About 68.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.72. Some equities with similar Price to Book (P/B) outperform the market in the long run. Alcon AG has Price/Earnings To Growth (PEG) ratio of 2.13. The entity last dividend was issued on the 13th of May 2025. Alcon, Inc. develops and manufactures eye care products for eye care professionals and their patients. operates independently of Novartis AG as of April 9, 2019. ALCON N operates under Medical Instruments Supplies classification in Switzerland and is traded on Switzerland Exchange. It employs 20000 people. For more info on Alcon AG please contact David Endicott at 41 589 112 110 or go to https://www.alcon.com.

Alcon AG Quarterly Total Revenue

2.61 Billion

Alcon AG Investment Alerts

Alcon AG generated a negative expected return over the last 90 days
Alcon AG is unlikely to experience financial distress in the next 2 years
About 68.0% of the company shares are held by institutions such as insurance companies
Latest headline from news.google.com: ALC.SW Alcon down 2. percent pre-market 04 Feb 2026 CHF60.48 near 50d support - Meyka

Alcon Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 30.03 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Alcon AG's market, we take the total number of its shares issued and multiply it by Alcon AG's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Alcon Profitablity

Alcon AG's profitability indicators refer to fundamental financial ratios that showcase Alcon AG's ability to generate income relative to its revenue or operating costs. If, let's say, Alcon AG is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Alcon AG's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Alcon AG's profitability requires more research than a typical breakdown of Alcon AG's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.1 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.13 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.13.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.07  0.08 
Return On Capital Employed 0.05  0.05 
Return On Assets 0.03  0.03 
Return On Equity 0.04  0.04 

Management Efficiency

Alcon AG has return on total asset (ROA) of 0.0262 % which means that it generated a profit of $0.0262 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0482 %, meaning that it generated $0.0482 on every $100 dollars invested by stockholders. Alcon AG's management efficiency ratios could be used to measure how well Alcon AG manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to climb to 0.08 in 2026. Return On Capital Employed is likely to climb to 0.05 in 2026. At this time, Alcon AG's Net Tangible Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to climb to about 492.5 M in 2026, whereas Non Current Assets Total are likely to drop slightly above 19.1 B in 2026.
Last ReportedProjected for Next Year
Book Value Per Share 50.13  47.49 
Tangible Book Value Per Share 7.32  7.68 
Enterprise Value Over EBITDA 19.52  24.63 
Price Book Value Ratio 1.75  1.26 
Enterprise Value Multiple 19.52  24.63 
Price Fair Value 1.75  1.26 
Leadership effectiveness at Alcon AG is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Dividend Yield
0.005
Operating Margin
0.1285
Profit Margin
0.1028
Forward Dividend Yield
0.0046
Beta
0.692

Technical Drivers

As of the 9th of February, Alcon AG shows the risk adjusted performance of 0.024, and Mean Deviation of 1.14. Alcon AG technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Alcon AG jensen alpha, semi variance, and the relationship between the standard deviation and value at risk to decide if Alcon AG is priced correctly, providing market reflects its regular price of 60.08 per share.

Alcon AG Price Movement Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Alcon AG Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Alcon AG price patterns.

Alcon AG Outstanding Bonds

Alcon AG issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Alcon AG uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Alcon bonds can be classified according to their maturity, which is the date when Alcon AG has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Alcon AG Predictive Daily Indicators

Alcon AG intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Alcon AG stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Alcon AG Forecast Models

Alcon AG's time-series forecasting models are one of many Alcon AG's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Alcon AG's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Alcon AG without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Commodity Directory Now

   

Commodity Directory

Find actively traded commodities issued by global exchanges
All  Next Launch Module

Alcon AG Corporate Management

Elected by the shareholders, the Alcon AG's board of directors comprises two types of representatives: Alcon AG inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Alcon. The board's role is to monitor Alcon AG's management team and ensure that shareholders' interests are well served. Alcon AG's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Alcon AG's outside directors are responsible for providing unbiased perspectives on the board's policies.

Additional Tools for Alcon Stock Analysis

When running Alcon AG's price analysis, check to measure Alcon AG's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alcon AG is operating at the current time. Most of Alcon AG's value examination focuses on studying past and present price action to predict the probability of Alcon AG's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alcon AG's price. Additionally, you may evaluate how the addition of Alcon AG to your portfolios can decrease your overall portfolio volatility.